Why the study?
Does abdominal nuclear magnetic resonance effectively diagnose nonalcoholic fatty liver disease in obese children and adolescents?
Does abdominal nuclear magnetic resonance effectively diagnose nonalcoholic fatty liver disease in obese children and adolescents?
Nuclear magnetic resonance is an effective noninvasive tool for diagnosing nonalcoholic fatty liver disease in obese children and adolescents, identifying a 28% prevalence in this cohort.
NMR may detect NAFLD in obese youth; leaves open validation against biopsy and long-term outcomes.
OBJECTIVE: To determine the frequency of nonalcoholic fatty liver disease using nuclear magnetic resonance as a noninvasive method. METHODOLOGY: This was a cross-sectional study conducted on 50 children and adolescents followed up at an outpatient obesity clinic. The subjects were submitted to physical examination, laboratory tests (transaminases, liver function tests, lipid profile, glycemia, and basal insulin) and abdominal nuclear magnetic resonance (calculation of hepatic, visceral, and subcutaneous fat). RESULTS: Nonalcoholic fatty liver disease was diagnosed in 14 (28%) participants, as a severe condition in eight (percent fat >18%), and as non-severe in four (percent fat from 9% to 18%). Fatty liver was associated with male gender, triglycerides, AST, ALT, AST/ALT ratio, and acanthosis nigricans. Homeostasis model assessment of insulin resistance and metabolic syndrome did not show an association with fatty liver. CONCLUSION: The frequency of nonalcoholic fatty liver disease in the present population of children and adolescents was lower than that reported in the international literature. It is suggested that nuclear magnetic resonance is an imaging exam that can be applied to children and adolescents, thus representing an effective noninvasive tool for the diagnosis of nonalcoholic fatty liver disease in this age range. However, further national multicenter studies with longitudinal design are needed for a better analysis of the correlation between nonalcoholic fatty liver disease and its risk factors, as well as its consequences.
No takes yet. Share an insight, caveat, or question.
Benetolo et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: